Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.86 is 21% below its 5-year average of 2.36, around the middle of its 5-year range (0.70–3.61).
As of the fiscal period ended Tuesday, June 30, 2026. 10.56% above its 12-month average of 1.68.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.86.
CURRENT RATIO
1.86
CURRENT RATIO AVG TTM
1.68
CURRENT RATIO AVG 3Y
2.10
CURRENT RATIO AVG 5Y
2.36
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+10.56%
CURRENT VS 3Y AVG
-11.31%
CURRENT VS 5Y AVG
-21.12%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 798 covered companies
CURRENT VS SECTOR MEDIAN
-48.25%
vs the sector median at left
Definitive Healthcare Corp.
Market Cap
$105.13M
Current Ratio
1.86
TTM Avg
1.68
3Y Avg
2.10
5Y Avg
2.36
Market Cap
$104.79M
Current Ratio
8.54
TTM Avg
8.31
3Y Avg
10.99
5Y Avg
13.36
Market Cap
$104.68M
Current Ratio
13.53
TTM Avg
12.93
3Y Avg
9.36
5Y Avg
9.36
Market Cap
$106.68M
Current Ratio
0.96
TTM Avg
1.08
3Y Avg
1.26
5Y Avg
1.56
Market Cap
$107.44M
Current Ratio
7.28
TTM Avg
6.67
3Y Avg
7.13
5Y Avg
10.02
Market Cap
$102.25M
Current Ratio
26.75
TTM Avg
10.50
3Y Avg
7.03
5Y Avg
10.82
Market Cap
$108.20M
Current Ratio
5.71
TTM Avg
10.50
3Y Avg
6.63
5Y Avg
5.88
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Definitive Healthcare Corp. (DH) | $105.13M | 1.86 | 1.68 | 2.10 | 2.36 |
| Anixa Biosciences, Inc. (ANIX)vs › | $104.79M | 8.54 | 8.31 | 10.99 | 13.36 |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | 13.53 | 12.93 | 9.36 | 9.36 |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.68M | 0.96 | 1.08 | 1.26 | 1.56 |
| Immunic, Inc. (IMUX)vs › | $107.14M | 5.05 | 1.26 | 3.56 | 6.57 |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $107.44M | 7.28 | 6.67 | 7.13 | 10.02 |
| The Joint Corp. (JYNT)vs › | $102.67M | 1.83 | 1.56 | 1.30 | 1.30 |
| OnKure Therapeutics, Inc. (OKUR)vs › | $102.25M | 26.75 | 10.50 | 7.03 | 10.82 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.20M | 5.71 | 10.50 | 6.63 | 5.88 |
| Outlook Therapeutics, Inc. (OTLK)vs › | $108.38M | 0.81 | 0.51 | 0.77 | 1.23 |
Current Ratio
1.86
Quick Ratio
1.86
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.86 |
| 2026-03-31 | 1.66 |
| 2025-12-31 | 1.64 |
| 2025-09-30 | 1.60 |
| 2025-06-30 | 1.65 |
| 2025-03-31 | 1.75 |
| 2024-12-31 | 2.30 |
| 2024-09-30 | 2.49 |
| 2024-06-30 | 2.40 |
| 2024-03-31 | 2.30 |
| 2023-12-31 | 2.23 |
| 2023-09-30 | 2.55 |
| 2023-06-30 | 2.84 |
| 2023-03-31 | 2.96 |
| 2022-12-31 | 2.94 |
| 2022-09-30 | 3.31 |
| 2022-06-30 | 3.32 |
| 2022-03-31 | 3.21 |
| 2021-12-31 | 3.61 |
| 2021-09-30 | 2.20 |
| 2021-09-17 | 0.70 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.72 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
